Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for… | ScholarDeck

Paper

Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

New research · Surgery

Journal of diabetes · 3w

Meta-analysisJournal of diabetes· Aug 2026

Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Oqab Baniowdeh, Ahmad Arar, Yusuf Muslih … Lela Shengelia

Read paper

Bariatric & Metabolic SurgeryMeta-analysisQ1IF 4.6

“

Random-effects model with Hartung-Knapp adjustment was used.

Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Oqab Baniowdeh … Lela Shengelia

Journal of diabetes · Aug 2026

Background

Comparison of percentage total body weight loss (%TWL) between metabolic bariatric surgery and incretin-based pharmacotherapy in adults with type 2 diabetes mellitus.

More results

Forest plot showing pooled mean difference in percentage total body weight loss (%TWL) between treatment groups.

Positive values favor metabolic bariatric surgery.

Read paper